Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Combination therapy versus monotherapy: which strategy is better?].

M Aellig1, E Battegay

  • 1Geriatriespital Adullam-Stiftung, Basel.

Praxis
|June 16, 2004
PubMed
Summary

For mild hypertension without organ damage, start with single blood pressure medication or a low-dose combination. Sequential monotherapy helps find the best drug, while early combination therapy is also effective.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Competences of internal medicine specialists for the management of patients with multimorbidity. EFIM multimorbidity working group position paper.

European journal of internal medicine·2023
Same author

Depressive symptoms, but not anxiety, predict subsequent diagnosis of Coronavirus disease 19: a national cohort study.

Epidemiology and psychiatric sciences·2022
Same author

Perspectives of European internists on multimorbidity. A multinational survey.

European journal of internal medicine·2022
Same author

Parallel processing in human visual cortex revealed through the influence of their neural responses on the visual evoked potential.

Vision research·2022
Same author

Comorbidities Associated with Worse Outcomes Among Inpatients Admitted for Acute Gastrointestinal Bleeding.

Digestive diseases and sciences·2021
Same author

Depression is independently associated with increased length of stay and readmissions in multimorbid inpatients.

European journal of internal medicine·2019

Area of Science:

  • Pharmacology
  • Cardiology
  • Internal Medicine

Background:

  • Pharmacological antihypertensive therapy is crucial for patients without target organ damage.
  • Mild hypertension (140-159 mmHg systolic or 90-99 mmHg diastolic) may be managed with monotherapy.
  • Individual patient response to antihypertensive drugs varies, necessitating personalized treatment selection.

Purpose of the Study:

  • To outline strategies for initiating antihypertensive therapy in patients without target organ damage.
  • To discuss the roles of monotherapy and combination therapy in managing mild hypertension.
  • To provide guidance on selecting appropriate antihypertensive drug combinations.

Main Methods:

  • Review of current pharmacological approaches to hypertension management.
  • Discussion of sequential monotherapy rotation for personalized drug selection.
  • Analysis of theoretical and practical considerations for combining different antihypertensive drug classes.

Main Results:

  • Monotherapy can effectively control blood pressure in mild hypertension.
  • Sequential rotation of monotherapies is recommended to identify the most effective drug for individual patients.
  • Early initiation of combination therapy is a viable alternative.
  • Combinations of Thiazid diuretics with Renin-Angiotensin-Aldosteron-System inhibitors are particularly effective.

Conclusions:

  • Initiating antihypertensive therapy with monotherapy or low-dose combination therapy is appropriate for patients without target organ damage.
  • Personalized drug selection through sequential monotherapy or early combination therapy is key to effective blood pressure control.
  • Specific drug combinations, such as Thiazid diuretics with RAAS inhibitors, offer significant therapeutic benefits.

Related Experiment Videos